Latest in FDA OK's painkiller designed to end opioids' addiction and overdose risk
Sort by
681 items
-
Feds: No evidence of Mizuhara gambling addiction
Federal prosecutors said Thursday that there was no evidence Ippei Mizuhara, the ex-interpreter of Shohei Ohtani, suffered from a gambling addiction, as he claimed when he asked a judge to limit ...ESPN - 1h -
FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.CNBC - 4h -
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.The New York Times - 19h -
FDA OK's painkiller designed to end opioids' addiction and overdose risk
Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.CBS News - 7h -
Black boxes found from crashed jet and FDA approves a new nonopioid painkiller: Morning Rundown
The D.C. plane crash renews concerns about air accidents in high-traffic areas.NBC News - 7h -
New non-opioid painkiller approved by US health agency
New drug suzetrigine, known by its brand name Journavx, has been approved to treat moderate to severe pain.BBC News - 16h -
FDA approves new type of non-opioid pain medication
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...The Hill - 17h -
US regulators approve new non-opioid drug to treat acute pain
Oral drug from Vertex, branded as Journavx, represents alternative to addictive opioids that have fueled US crisis . The US Food and Drug Administration approved a new drug to treat acute pain, the ...The Guardian - 19h -
FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex Pharmaceuticals said.NBC News - 21h -
On board Nanusa, a design jewel on the Nile
Goya Gallagher’s vintage Egyptian houseboat makes a stunning showcase for her homeware rangeFinancial Times - 1d -
GPs asked to identify potential gambling addicts
The health watchdog says gambling should be given the same weight as alcohol and nicotine addiction.BBC News - 3d -
Cowboys hire Brian Schottenheimer: How Jerry Jones' coach search ended with 'as big a risk as you could take'
Jones made a comfortable decision despite him saying otherwiseCBS Sports - 3d -
There’s a word for people who prefer phones to meeting friends: addicts | Martha Gill
Ditching hanging out for isolated scrolling on our sofas is a dangerous habit that warrants help on a par with gambling. Over the decades, research has chipped away at our most cherished ideas ...The Guardian - 6d -
Purdue and Sackler family agree to $7.4bn opioid settlement with US states
New deal is $1.4bn higher than previous one struck down by Supreme Court last yearFinancial Times - Jan. 23 -
Sacklers Up Their Offer to Settle Purdue Opioids Cases, With a New Condition
A group of 15 states have reached a tentative new deal that would require them to set aside hundreds of millions of dollars from the settlement in a legal-defense fund for the family.The New York Times - Jan. 23 -
Purdue Pharma, Sacklers reach new settlement agreement in opioid cases
Purdue Pharma and the members of the Sackler family who own the company agreed in principle to pay a $7.4 billion settlement to resolve thousands of lawsuits over their alleged role in the opioid ...The Hill - Jan. 23 -
Purdue Pharma, Sackler family to pay $7.4 billion opioid settlement
Purdue Pharma, the manufacturers of OxyContin, and members of the family that own the company, will pay billions to victims of the opioid crisis, as well as state and local governments.NBC News - Jan. 23 -
Purdue Pharma and Sacklers reach new $7.4bn settlement over opioids crisis
Settlement resolves thousands of lawsuits alleging Oxycontin caused addiction crisis. The Sackler family, which owns the OxyContin maker Purdue Pharma, has agreed to pay up to $7.4bn in a ...The Guardian - Jan. 23 -
Sacklers, Purdue Pharma reach $7.4 billion settlement in opioid lawsuits
Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.ABC News - Jan. 23 -
World’s addiction to fossil fuels is ‘Frankenstein’s monster’, says UN chief
António Guterres issues warning at Davos, days after Donald Trump pulled US out of Paris climate agreement. Davos day two live – latest updates The world’s addiction to fossil fuels is a ...The Guardian - Jan. 22 -
Xi Tells Officials Scared of Being Purged: It's OK to Make Mistakes
Chinese leader Xi Jinping’s decree to the Communist Party: Enforcing strict discipline shouldn’t fuel a climate of fear that saps the can-do spirit that once helped power China’s economic rise.The Wall Street Journal - Jan. 19 -
DOJ hits Walgreens with lawsuit for filling 'unlawful' opioid prescriptions
The Department of Justice (DOJ) hit drugstore chain Walgreens with a lawsuit this week for filling “unlawful” opioid prescriptions that had no “legitimate” medical purpose for over a decade. The ...The Hill - Jan. 18 -
US accuses Walgreens of filling millions of illegitimate prescriptions, including for opioids
The U.S. Justice Department has filed a lawsuit accusing Walgreens of filling millions of prescriptions for Americans over the last decade and more without a legitimate purpose, including for ...ABC News - Jan. 17 -
'Are u OK?': Angelenos share their text exchanges amid wildfire devastation
Los Angeles residents leaned on one another for support over text messages as wildfires raged in the area.NBC News - Jan. 18 -
U.S. Sues Walgreens for Role in Opioid Crisis
The pharmacy chain since August 2012 filled prescriptions that lacked a legitimate medical purpose, were invalid or weren’t issued in professional practice, the Justice Department said.The Wall Street Journal - Jan. 17 -
Philip Morris’s Zyn nicotine pouch isn’t safe, but FDA gives OK to marketing it
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine pouches.MarketWatch - Jan. 16 -
FDA will allow Zyn nicotine pouches to stay on the market
Zyn products will be allowed to stay on the market after federal health officials Thursday said the popular nicotine pouches can help adult smokers cut back or switch completely. The Food and Drug ...The Hill - Jan. 16 -
U.S. sees largest decline ever in drug overdose deaths over a year-long period
New data released by the U.S. Centers for Disease Control and Prevention revealed the largest drop in overdose deaths ever recorded in the U.S. over a 12-month period. Between August 2023 and ...CBS News - Jan. 15 -
'Drug-addicted rats' infesting Houston police evidence room
"Drug-addicted rats" are eating narcotics seized and stored by Houston police, prompting a change in how long the police department is required to store the evidence, officials said.NBC News - Jan. 15 -
Oil prices end higher as traders weigh demand prospects, supply risks
Oil futures settled higher Wednesday, finding support after snapping a three-day winning streak that had been driven in part by wider U.S. sanctions on Russia as well as cold weather in much of the ...MarketWatch - Jan. 15 -
Police report says former MLB pitcher Brian Matusz died at 37 of likely overdose
The former Baltimore Orioles pitcher Brian Matusz died at the age of 37 after an apparent drug overdose, according to police documents. The Orioles announced Matusz’s death last week. According ...Yahoo Sports - Jan. 14 -
Ex-McKinsey partner pleads guilty to destroying records on opioids
Martin Elling pleads guilty to destroying records on advice provided to Purdue Pharma on how to ‘turbocharge’ sales. A former partner at McKinsey & Co pleaded guilty on Friday to obstructing ...The Guardian - Jan. 10 -
Fast fashion is an addiction. Secondhand mania may be just as bad | Chloë Hamilton
I loved to scour apps and charity shops for cheap clothes and toys – but now I know it is another kind of overconsumption. ‘Guess how much this was,” I say to my partner mischievously, revealing ...The Guardian - Jan. 10 -
U.S. overdose deaths far outpace other countries: Report
The United States has the highest rate of drug overdose deaths out of 30 countries, according to a new report from the health nonprofit the Commonwealth Fund. Overdose deaths in the U.S. dipped ...The Hill - Jan. 10 -
Kroger agrees to pay $110M to Kentucky in opioid settlement
The Kroger Co. has agreed to pay Kentucky $110 million to settle a lawsuit filed last year alleging it pumped millions of doses of opioids into the state over the course of more than a decade. ...The Hill - Jan. 9 -
FDA sets limits on lead in some baby foods
But consumer advocates say the Food and Drug Administration's new guidance on lead limit in baby food doesn't go far enough.CBS News - Jan. 6 -
FDA limits toxic lead in some baby foods
The FDA set maximum levels for lead in baby foods like jarred fruit, yogurts and dry cereal, part of an effort to reduce kids’ exposure to the toxic metal.NBC News - Jan. 6 -
DMC and Niko Moon launch initiative for addiction support at concerts
DMC of Run-DMC and country star Niko Moon join forces with "One Million Strong" to create sober-friendly spaces at concerts, helping fans and artists affected by addiction.CBS News - Jan. 6 -
I’ve been waging war on my phone addiction | Rhik Samadder
My progress has been painfully slow, but at last I think I’m winning. A few years ago I found myself in the toilet without my phone and experienced a surge of actual panic. How was I supposed to ...The Guardian - Jan. 5 -
Why It’s OK for Fans to Boo Their Favorite Teams
Spectators pay to sit in their seats and have the right to express their frustration, a columnist for The Athletic writes.The New York Times - Jan. 2
